What one share of NewcelX holds
NewcelX is a clinical-stage pharmaceutical company focused on developing and manufacturing “off-the-shelf”, allogeneic, proprietary cell products based on its technology platform for the expansion and differentiation of hESCs into functional cells.
NewcelX’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Profit | $2.16 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.72 |
| Cash and investments | $0.46 |
| Book value | $1.51 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$32.99 | — | — | — | −$56.50 |
| 2019 | — | −$31.85 | — | — | — | −$35.47 |
| 2020 | — | −$16.45 | — | — | — | −$51.63 |
| 2021 | — | −$40.15 | $0.13 | −$50.33 | — | $1.34 |
| 2022 | — | −$33.52 | — | — | — | $0.14 |
| 2023 | — | $1.13 | $0.00 | −$1.17 | — | — |
| 2024 | — | $2.43 | $0.00 | −$0.36 | — | −$2.70 |
| 2025 | — | $2.16 | $0.00 | −$0.72 | — | $1.51 |
Common questions about NewcelX
How much does one share of NewcelX earn?
Over its latest fiscal year, each share of NewcelX earned $2.16 of profit.
Does NewcelX pay a dividend?
NewcelX didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is NewcelX’s book value per share?
NewcelX’s book value is $1.51 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.
How much cash and debt does each share of NewcelX have?
Each share of NewcelX has $0.46 of cash and investments, as of December 31, 2025.
What is NewcelX’s free cash flow per share?
−$0.72 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has NewcelX bought back shares?
NewcelX’s share count rose about 2364% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.